在Usher综合征1F型模型中,PCDH15双AAV基因疗法用于耳聋和失明
Maryna V Ivanchenko1, Daniel M Hathaway1, Eric M Mulhall1
1Department of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA.
The Journal of clinical investigation
|October 23, 2024
概括
对阿舍尔综合征1F型 (USH1F) 的基因治疗使用双AAV系统来输送PCDH15基因. 这种方法在小鼠模型中成功恢复了听力和平衡,并在视网膜组织中显示出有希望的结果.
科学领域:
- 遗传学 遗传学 是一个
- 眼科医生 眼科 眼科
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 艾舍氏综合征1F型 (USH1F) 是一种遗传性疾病,导致先天性听力和平衡丧失,以及渐进的视力障碍.
- 原cadherin-15 (PCDH15) 基因的突变是USH1F的原因.
- 目前的基因治疗方法面临的挑战是将全长的PCDH15基因包装成单个腺相关病毒 (AAV).
研究的目的:
- 开发和评估一种双AAV基因治疗策略,用于在Usher综合征1F型中输送全长PCDH15基因.
- 评估这种双AAV方法在恢复USH1F小鼠模型中的听力和平衡功能的有效性.
- 在相关的人类视网膜模型中确定这种基因疗法的潜力.
主要方法:
- 设计了一种双AAV向量系统,以提供完整的PCDH15编码序列,克服单个AAV包装的限制.
- 治疗疗效在专门针对阿舍尔综合征1F型开发的小鼠模型中进行了测试.
- 分析了PCDH15蛋白表达在人类视网膜器官和非人类灵长类动物视网膜扩展物中.
主要成果:
- 双AAV策略成功地在USH1F小鼠模型中产生了全长PCDH15基因.
- 在接受USH1F治疗的小鼠中观察到听力和平衡功能的恢复.
- 在人类视网膜有机体和灵长类动物视网膜中的光受体和体过程中证实了有效的PCDH15蛋白表达.
结论:
- 双AAV方法代表了提供PCDH15等大型基因的可行策略,用于阿舍尔综合征1F型基因治疗.
- 这种方法显示出解决与USH1F相关的听力,平衡和视力障碍的巨大潜力.
- 这种双AAV系统的进一步开发可以为治疗USH1F的临床应用铺平道路.
相关概念视频
Unrenewable Cells
2.3K
In humans, the photoreceptor cells of the eye and sensory hair cells of the ear lack stem cells. These cells are thus unrenewable and cannot be replaced when they are damaged or destroyed.
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
2.3K
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K


